Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes a review of clinical effectiveness, cost-effectiveness, and guidelines
This report aims to summarize the comparative clinical effectiveness and comparative cost-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes, as well as relevant evidence-based guidelines for the pharmacologic management of diabetes
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
June 14, 2019, 2019
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references